While I don't like the pps action that we have seen thus far today. I am most encouraged by the evaluation agreement due to multiple products to be tested for suitability utilizing PSDV systems. It sounds as if they are all in on this one. A little discouraging in one sense but hold on our payday is coming if you can gut it out.I still buying.
Tom, Shorts jumped all over us this morning following the pop to $2.50. I'm holding steady. I'm no longer trading a share. I'm way good on my average and will hold through pending catalysts in the fall. I hope the shorts gag on it. Some day it will only be going up and licensing deals will be followed by the FDA approval of Iluvien for chronic DME. I see easy $7 by fall and the shorts will be buying it all back. They've been getting away with this far too long.